Trial
NCT04140539
A Clinical Study to Enable Process Validation of Commercial Grade OTL-101
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
—
Condition
Severe Combined Immunodeficiency Due to ADA Deficiency
Intervention
OTL-101
Why stopped
Recruitment on hold for business reasons. Study will not be performed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-03